Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Frazier Life Sciences Public Fund, L.P. reported a 2.30% stake in Kalvista Pharmaceuticals, Inc. (Schedule 13D/A)
Event May 19, 2026 · Filed May 21, 2026
Frazier Life Sciences Public Fund, L.P. reported a 2.30% stake in Kalvista Pharmaceuticals, Inc., 1,249,165 shares, with active intent on May 19, 2026. Filed May 21, 2026 (Schedule 13D/A).
- Stake
- 2.30%
- Shares
- 1,249,165
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 14 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 2.30% | 1,249,165 |
| FHMLSP, L.P. | 2.30% | 1,249,165 |
| FHMLSP, L.L.C. | 2.30% | 1,249,165 |
| Frazier Life Sciences X, L.P. | 0.80% | 427,983 |
| FHMLS X, L.P. | 0.80% | 427,983 |
| FHMLS X, L.L.C. | 0.80% | 427,983 |
| Frazier Life Sciences XI, L.P. | 0.30% | 145,592 |
| FHMLS XI, L.P. | 0.30% | 145,592 |
| FHMLS XI, L.L.C. | 0.80% | 145,592 |
| Frazier Life Sciences XII, L.P. | 0% | 6,563 |
| FHMLS XII, L.P. | 0% | 6,563 |
| FHMLS XII, L.L.C. | 0% | 6,563 |
| James N. Topper | 0.80% | 427,983 |
| Patrick J. Heron | 0.80% | 427,983 |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Kalvista Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Frazier Life Sciences Public Fund, L.P. · Nov 4, 2025
- Schedule 13D/A · Frazier Life Sciences Public Fund, L.P. · Aug 20, 2025
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026